Navigation LinksBiology NewsHealth NewsBiology TechnologyMedicine Technology


Helix Biopharma to Present L-DOS47 Lung Cancer Research Findings at the Fourth International Conference on Tumor Microenvironment in Florence, Italy

- Helix BioPharma Corp. (TSX: HBP /Frankfurt: WKN918864) AURORA, ON, March 5 /CNW/Dr. Heman Chao, Vice President of Researchat Helix BioPharma Corp., a developer of novel cancer therapeutics,will be presenting a scientific poster at the Fourth InternationalConference on Tumor Microenvironment, which runs from March 6th to10th in Florence, Italy. The conference, hosted by the...

Replidyne Phase II Pediatric Trial Meets Primary Objective

LOUISVILLE, Colo., March 06, 2007 /PRNewswire-FirstCall/ --Replidyne, Inc. announced today that it has completed its Phase IIclinical trial using faropenem medoxomil (faropenem) in pediatricpatients with acute otitis media (AOM), a common infection of themiddle ear. Initial analyses of the study results show that it metits primary objective to show that faropenem was effective ineradicatin...

DVT Awareness Survey Findings: Heart and Respiratory Patients

WASHINGTON, March 06, 2007 /PRNewswire/ -- Up to two millionAmericans are affected each year by DVT, with up to 600,000hospitalized. Its primary complication, pulmonary embolism (PE),claims up to 300,000 lives annually -- more than breast cancer andAIDS combined. People who suffer from cardiovascular disease may beat increased risk for DVT, because these factors also heighten thelikelihood...

Pozen Announces Positive Outcome for PA 325

Chapel Hill, N.C., March 6, 2007-Pozen Inc. (NASDAQ: POZN),today announced top-line results of its "Safer Aspirin" PA 325proof-of-concept study conducted during the fourth quarter of 2006.PA 325 is a patented formulation of 325mg of aspirin surrounded bya 20mg coating of an immediate release formulation of a proton pumpinhibitor. The PA 325, 28 day study, involved two groups of 40 subject...

Advanced Magnetics Announces Presentation of Ferumoxytol Data at the National Kidney Foundation 2007 Spring Clinical Meetings

CAMBRIDGE, Mass., March 06, 2007 /PRNewswire-FirstCall/ --Advanced Magnetics today announced that data from three completedPhase III multi- center clinical studies of ferumoxytol as anintravenous iron replacement therapeutic will be presented duringthe National Kidney Foundation (NKF) 2007 Spring Clinical Meetingstaking place April 10th through 14th in Orlando, Florida. Twoposters containi...

POZEN Announces Positive Outcome for PA 325 Proof of Concept Study

CHAPEL HILL, N.C.--(BUSINESS WIRE)--Mar 6, 2007 - POZEN Inc.(NASDAQ: POZN), today announced top-line results of its "SaferAspirin" PA 325 proof-of-concept study conducted during the fourthquarter of 2006. PA 325 is a patented formulation of 325mg ofaspirin surrounded by a 20mg coating of an immediate releaseformulation of a proton pump inhibitor. The PA 325, 28 day study, involved two group...

Nventa Announces Presentation of Positive HspE7 Data from NCI-Sponsored Clinical Trial in Cervical Dysplasia

- 78 Percent of Patients Showed Complete Response or Reduction ofLesion Size by More than Fifty Percent - SAN DIEGO, CA, March 05, 2007 /PRNewswire-FirstCall/ - NventaBiopharmaceuticals Corporation today announced the presentation ofpositive results from a clinical trial examining the safety andefficacy of pilot process HspE7, an investigational therapeuticvaccine for human papillomavirus (...

AOP Orphan Pharmaceuticals and Lantibio Announce Positive Phase II Study with Novel Cystic Fibrosis Therapy

VIENNA, Austria and CHAPEL HILL, N.C., US, March 06, 2007/PRNewswire/ -- AOP Orphan Pharmaceuticals AG ("AOP Orphan") andLantibio, Inc. ("Lantibio") today announced positive final resultsfrom their placebo controlled, double-blinded Phase II clinicalstudy of Moli1901, an experimental compound to treat cysticfibrosis ("CF"). Moli1901 is being developed by AOP Orphan inEurope under a licensi...

Advanced Cell Technology's Ability to Rescue Vision in Blind Rats Noted in Scientific American

ALAMEDA, Calif.--(BUSINESS WIRE)--Mar 5, 2007 - Advanced CellTechnology, Inc.'s (OTCBB: ACTC) ability to rescue vision in blindrats was noted in Scientific American's March 2007 issue as thelead story of its News Scan section. The full text of the article,which notes Advanced Cell's ability to "coax embryonic stem cellsto turn into transplantable retinal pigment epithelial (RPE)tissue," is...

Accentia Biopharmaceuticals Scientific Presentations Demonstrate Increasing Acceptance of Fungal Etiology of Chronic Sinusitis at the Annual Meeting of the American Academy of Allergy, Asthma, and Immunology

TAMPA, Fla.--(BUSINESS WIRE)--Mar 7, 2007 - AccentiaBiopharmaceuticals, Inc. (NASDAQ: ABPI), presented three posters atthe Annual Meeting of the American Academy of Allergy, Asthma, andImmunology from February 23 - 27, 2007 in San Diego, CA. Theposters discussed findings from a survey of 202 otolaryngologists(ENTs) and allergists in the U.S., U.K., France, and Germany on theburden of chroni...
[next]
(Date:4/19/2019)... ... April 19, 2019 , ... According to the Environmental ... alone comes with pesticide residue. Pesticides are sprayed on produce to repel insects, but ... what make up that thin, waxy layer that covers the skin of most produce ...
(Date:4/19/2019)... CLEMENTE, Calif. (PRWEB) , ... April 18, 2019 , ... ... market continues to expand. The deodorants combine the power of 100% pure essential oils ... actually works. , Not only is Edens Garden’s latest product release all-natural but ...
(Date:4/18/2019)... , ... April 18, 2019 , ... Swiss Pet company ... range is designed to support the bond between human and animal while improving the ... by certified Swiss herbal specialists with decades of experience. They are made by hand ...
(Date:4/18/2019)... ... April 18, 2019 , ... The Coro Medical official sweepstakes grand prize winner ... , As a small, volunteer-only department in rural Mississippi, Livingston entered the national ... is the only department with life-saving equipment of this caliber in Panola County. , ...
(Date:4/17/2019)... ... April 17, 2019 , ... Kadan Homecare, an award-winning provider of ... that it has received both the 2019 Best of Home Care® – Provider of ... only to the top-ranking home care providers, based on client and caregiver satisfaction scores ...
Breaking Medicine News(10 mins):
... /PRNewswire-FirstCall/ - (OTCBB: GVBP.OB) - GENova Biotherapeutics, Inc., ("GENova"), ... strategy and its unique niche in the drug development ... the latest generation of biotherapeutic technologies that can cure ... on prostate and breast cancers, GENova has acquired a ...
... MUMBAI, India, September 9 , ... to Celebrate Best in the,Industry , ... excellence in,Healthcare Awards, at Mumbai. The Event attended by the ... that have performed,par excellence and demonstrated best practices. Recognizing the ...
... ... Flag Rules, HIPAA and HITECH Act guidelines for network and data security to protect ... ... Consulting, Inc. , a medical billing and practice management consulting company located outside of ...
... ... contract to provide customized web-based transcription services for Consolidated Services Group (CSG), an industry ... ... 9, 2009 -- ZyDoc Medical Transcription announced today that it has signed a contract ...
... ... pMDsoft, Inc. today announced the completion of over ... and popular software systems in the medical industry. pMDsoft,s industry-leading ... existing software infrastructure, eliminating data entry and increasing the accuracy of ...
... , Democratic National Committee Members To Gather September ... Tribute to Highlight Meeting , , WASHINGTON, ... Committee will meet this Thursday, September 10 through Saturday, September ... full DNC meeting on Friday, members will hear a major ...
Cached Medicine News:
The Lineage acetabular system with ceramic liners uses sophisticated manufacturing methods and materials to minimize wear debris generation....
Hemisphere modular Cup....
Cer-Met series II system....
Derived from an extensive study into increasing the range of motion in hip replacement, the cemented SHP acetabular cup is a unique design and is manufactured from ArCom polyethylene....
Medicine Products:
(Date:4/17/2019)... ... April 17, 2019 , ... Dr. Srini Pillay, a best-selling author, ... chunk of his career subverting ideas on creativity and the processes behind human thinking. ... now he’s ready to share his thoughts on social media and the suppression of ...
(Date:4/17/2019)... ... April 17, 2019 , ... ... focused on novel therapies for diseases involving mitochondrial dysfunction, announced yesterday at ... the Phase 2/3 TAZPOWER and open-label extension (OLE) clinical trial evaluating efficacy ...
(Date:4/17/2019)... ... ... The Job Research Foundation has announced the recipients of its first ... for Job Syndrome. , The Foundation awarded three two-year grants of $200,000 each ... countries, and on three continents. The recipients are: , ...
Breaking Medicine Technology:
... March 19, 2012  Reportlinker.com ... market research report is ... ... – Gram-negative combination antibiotics ...
... 19, 2012 Reportlinker.com announces that a ... its catalogue: Pharmaceuticals: ... http://www.reportlinker.com/p0191852/Pharmaceuticals-Global-Industry-Guide.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pharmaceu Pharmaceuticals: Global ... top-level data and analysis covering the Pharmaceuticals ...
Cached Medicine Technology: